Atmo Biosciences has received US Food and Drug Administration (FDA) 510(k) regulatory clearance...
Imugene Limited (ASX:IMU, OTC:IUGNF) (ASX:IMU) (OTCMKTS:IUGNF) is well-funded and ready to...
Every day, there seems to be a biotech breakthrough on Australian soil, and while many of the...
Race Oncology Ltd (ASX:RAC) is advancing its Phase 2/3 cancer drug Zantrene which is a potent...
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF)CEO Dr. James Garner talked with Proactive about the company’s newly signed global exclusive license agreement with Hummingbird Bioscience. This agreement allows Percheron to develop, manufacture, and commercialize HMBD-002, an immuno-oncology drug...
